Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2612350

Words ABSCI
Image
Image description
Status registered: Registered/protected
Priority date 05 Dec 2025 (Convention)
Classes 40, 42
Kind Fancy
Dates
Renewal due 15 Dec 2035
Registration advertised / published 13 Jul 2026
Entered on Register 13 Jul 2026
Acceptance advertised / published 06 May 2026
Acceptance 21 Jan 2026
Filing 15 Dec 2025
Registered from 15 Dec 2025

Owner Address for service
Absci Corporation
PHILLIPS ORMONDE FITZPATRICK

Goods & Services
Class 40: Biotechnological services, namely, custom production and purification of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services, namely, custom production of cell lines to produce proteins, such as hormones, cytokines, antibodies and antibody fragments
Class 42: Scientific and technological consulting services relating to producing, assaying, and purifying biotechnological products; research and development in the pharmaceutical and biotechnology fields; services of biotechnical and pharmacological laboratories, namely, scientific and technological research relating to the production of biotechnological products for use in preparing pharmaceutical preparations; scientific and technological research relating to the production of biotechnological products for use in preparing pharmaceutical preparations, and scientific consultation related thereto; scientific research, namely, carrying out feasibility studies relating to the production of biotechnological products for use in preparing pharmaceutical preparations; discovery of pharmaceutical preparations, medicines and medicaments; technological services, namely, technological consultation relating to the production of biotechnological products for use in preparing pharmaceutical preparations; Bioinformatics research services, namely, analyzing complex biological data through the use of artificial intelligence, and testing and evaluation of biologics through artificial intelligence; computer assisted biologics design involving the use of artificial intelligence technology; Biotechnological services, namely, discovery of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services, namely, discovery of cell lines to produce proteins, such as hormones, cytokines, antibodies and antibody fragments

Convention details
Date 05 Dec 2025
Number 99/532,186
Country UNITED STATES OF AMERICA

Indexing constituents
Word Image